Get started
Work

Abstract C112: Cabozantinib eradicates advanced murine prostate cancer by activating anti-tumor innate immunity

Year: 2015
Type: conference-abstract
DOI: 10.1158/1535-7163.targ-15-c112
Authors: Akash Patnaik, Kenneth Swanson, Sabina Signoretti, Huihui Ye, Eva Csizmadia, Jesse Novak, Marina Gehring, Katja Helenius, Athalia Pyzer, Laleh Montaser, Lily Wang, Olivier Elemento, Elena Levantini, John Clohessy, John Asara, Kathleen Kelly, Pier Paolo Pandolfi, Jacalyn Rosenblatt, David Avigan, Steven Balk, Lewis Cantley
Institutions: Harvard University, Brigham and Women's Hospital, Beth Israel Deaconess Medical Center, Massachusetts Institute of Technology, Weill Cornell Medicine, National Cancer Institute
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W2407334388
Cites:
Cited by:
Related to: 10